• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Colchicine in Patients With Acute Coronary Syndrome: Two-Year Follow-Up of the Australian COPS Randomized Clinical Trial.

作者信息

Tong David C, Bloom Jason E, Quinn Stephen, Nasis Arthur, Hiew Chin, Roberts-Thomson Philip, Adams Heath, Sriamareswaran Rumes, Htun Nay M, Wilson William, Stub Dion, van Gaal William, Howes Laurie, Yeap Allysha, Yip Brian, Wu Sam, Perera Padeepa, Collins Nicholas, Yong Andy, Bhindi Ravinay, Whitbourn Robert, Lee Astin, Premaratne Manuja, Asrress Kaleab, Freeman Melanie, Amerena John, Layland Jamie

机构信息

St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia (D.C.T., R.W., J.L.).

Cardiology, Department of Medicine, Peninsula Health, Frankston, Victoria, Australia (D.C.T., J.E.B., R.S., N.M.H., A. Yeap, B.Y., S.W., P.P., M.P., J.L.).

出版信息

Circulation. 2021 Nov 9;144(19):1584-1586. doi: 10.1161/CIRCULATIONAHA.121.054610. Epub 2021 Nov 8.

DOI:10.1161/CIRCULATIONAHA.121.054610
PMID:34748393
Abstract
摘要

相似文献

1
Colchicine in Patients With Acute Coronary Syndrome: Two-Year Follow-Up of the Australian COPS Randomized Clinical Trial.秋水仙碱用于急性冠脉综合征患者：澳大利亚COPS随机临床试验的两年随访
Circulation. 2021 Nov 9;144(19):1584-1586. doi: 10.1161/CIRCULATIONAHA.121.054610. Epub 2021 Nov 8.
2
Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial.秋水仙碱治疗急性冠状动脉综合征患者的疗效：澳大利亚 COPS 随机临床试验
Circulation. 2020 Nov 17;142(20):1890-1900. doi: 10.1161/CIRCULATIONAHA.120.050771. Epub 2020 Aug 29.
3
Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies.秋水仙碱与心血管结局：对近期研究的批判性评价。
Curr Atheroscler Rep. 2021 May 10;23(7):32. doi: 10.1007/s11883-021-00932-5.
4
Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial.秋水仙碱对比安慰剂对急性冠脉综合征或急性脑卒中患者高敏 C 反应蛋白的影响：一项先导随机对照试验。
J Thromb Thrombolysis. 2012 Jan;33(1):88-94. doi: 10.1007/s11239-011-0637-y.
5
Colchicine Use in Acute Coronary Syndromes: An Update.秋水仙碱在急性冠状动脉综合征中的应用：最新进展
Angiology. 2021 Jul;72(6):503-510. doi: 10.1177/0003319720985644. Epub 2021 Jan 8.
6
The Role of Colchicine in Acute Coronary Syndromes.秋水仙碱在急性冠状动脉综合征中的作用。
Clin Ther. 2019 Jan;41(1):11-20. doi: 10.1016/j.clinthera.2018.07.023. Epub 2018 Sep 2.
7
Acute coronary syndromes, seedless watermelons, and colchicine.急性冠状动脉综合征、无籽西瓜与秋水仙碱。
Clin Ther. 2013 Aug;35(8):1051-2. doi: 10.1016/j.clinthera.2013.07.424.
8
Efficacy of Colchicine in the Treatment of Patients With Coronary Artery Disease: A Mini-Review.秋水仙碱治疗冠状动脉疾病患者的疗效：小型综述。
Clin Ther. 2022 Aug;44(8):1150-1159. doi: 10.1016/j.clinthera.2022.06.009. Epub 2022 Jul 28.
9
Is There a Role for Colchicine in Acute Coronary Syndromes?秋水仙碱在急性冠状动脉综合征中是否有作用？
J Am Heart Assoc. 2015 Aug 24;4(8):e002372. doi: 10.1161/JAHA.115.002372.
10
Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation.秋水仙碱疗法对急性冠脉综合征患者的作用是通过作用于半胱天冬酶-1来抑制NLRP3炎性小体单核细胞激活。
Clin Sci (Lond). 2016 Jul 1;130(14):1237-46. doi: 10.1042/CS20160090. Epub 2016 Apr 21.

引用本文的文献

1
Inflammation in atherosclerotic cardiovascular disease: From diagnosis to treatment.动脉粥样硬化性心血管疾病中的炎症：从诊断到治疗。
Eur J Clin Invest. 2025 Jul;55(7):e70020. doi: 10.1111/eci.70020. Epub 2025 Mar 8.
2
Potential Impact of Colchicine on Atherosclerotic Cardiovascular Disease in the United States.秋水仙碱对美国动脉粥样硬化性心血管疾病的潜在影响
JACC Adv. 2025 Mar;4(3):101622. doi: 10.1016/j.jacadv.2025.101622. Epub 2025 Feb 15.
3
[Colchicine-Phoenix from the ashes].[秋水仙碱——浴火重生]
Wien Klin Wochenschr. 2025 Feb;137(Suppl 1):1-33. doi: 10.1007/s00508-024-02490-7. Epub 2025 Feb 6.
4
Colchicine in acute coronary syndromes: the present and the possible future.秋水仙碱在急性冠状动脉综合征中的应用：现状与可能的未来。
Nat Rev Cardiol. 2025 Apr;22(4):215-216. doi: 10.1038/s41569-025-01124-3.
5
Inflammation in the Peri-ACS Period: Ready for Prime Time?急性冠状动脉综合征（ACS）围手术期炎症：准备好进入黄金时代了吗？
Curr Atheroscler Rep. 2024 Dec 23;27(1):20. doi: 10.1007/s11883-024-01263-x.
6
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials.秋水仙碱用于缺血性中风和动脉粥样硬化事件的二级预防：随机试验的荟萃分析
EClinicalMedicine. 2024 Oct 8;76:102835. doi: 10.1016/j.eclinm.2024.102835. eCollection 2024 Oct.
7
Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases.针对心血管疾病炎症的新型治疗方法和即将开展的临床试验。
Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):2371-2395. doi: 10.1161/ATVBAHA.124.319980. Epub 2024 Oct 10.
8
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients Following Acute Coronary Syndromes: From Lipid Lowering and Plaque Stabilization to Improved Outcomes.急性冠状动脉综合征患者中9型前蛋白转化酶枯草杆菌蛋白酶/克新蛋白酶抑制剂：从降脂、斑块稳定到改善预后
J Clin Med. 2024 Aug 25;13(17):5040. doi: 10.3390/jcm13175040.
9
Role of inflammation and evidence for the use of colchicine in patients with acute coronary syndrome.炎症的作用及秋水仙碱在急性冠脉综合征患者中应用的证据
Front Cardiovasc Med. 2024 Jun 27;11:1356023. doi: 10.3389/fcvm.2024.1356023. eCollection 2024.
10
Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes.对白细胞介素-1抑制剂和秋水仙碱在2型糖尿病炎症控制中作用的新见解。
Diabetol Metab Syndr. 2024 Jun 25;16(1):140. doi: 10.1186/s13098-024-01369-x.